Sitemap - 2026 - Big Pharma Sharma

Last Week Tonight in BioPharma: Week of May 4th

Last Week Tonight in Biopharma: Week of April 27th, 2026

Should You Be Allowed to Bet on Whether a Cancer Drug Works?

Last Week Tonight in BioPharma | Week of April 21st, 2026

Last Week Tonight in BioPharma: April 11th - April 19th

The GLP-1 You Probably Haven't Heard Of

Last Week Tonight in BioPharma: April 4th - April 10th

Last Week Tonight in BioPharma: March 28th - April 3rd

Biogen’s Great Molt is Complete

Last Week Tonight in BioPharma: March 20th - 27th

Reclaiming the Narrative: What BioPharma Must Learn From Tech Before It's Too Late

Who's Actually Earning Their Seat at the Table?

Drug Dealin Ep. 9: Using AI to Find Novel Treatment Options

Why Gilead Really Bought Arcellx

The FDA Decision That Just Setback America's mRNA Vaccine Industry

Consulting & Advisory Work

Drug Dealin Ep. 8: 2026 Predictions

Big Pharma at JPM 2026: M&A, Obesity, and China

Six Biotechs Getting Acquired in 2026

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts